(IN BRIEF) Brenntag Pharma has signed a strategic partnership with Evonik REXIM for the exclusive distribution of REXIM® GMP-grade amino acids across most of Europe. The agreement took effect on 1 July 2026 and covers regions including DACH, the UK, … Read the full press release
Posted in Business, Chemicals, Germany, Healthcare, International Trade, Pharma & Biotech
Tagged active pharmaceutical ingredients, APIs, Benelux, bioconversion, biopharma, biopharmaceutical manufacturing, Brenntag, Brenntag and Evonik Build Stronger European Supply Network for GMP-Grade Amino Acids, Brenntag Expands API and Biopharma Offering With REXIM® Amino Acids Agreement, Brenntag Pharma, cell culture media, Central and Eastern Europe, DACH, Europe, Evonik, Evonik Health Care, Evonik REXIM, excipients, fermentation, France, GMP amino acids, Israel, Joakim Rehné, life sciences, Market development, Medical Nutrition, pharmaceutical grade amino acids, pharmaceutical ingredients, regulatory know-how, REXIM, Scandinavia, Strategic Partnership Gives Brenntag Wider Role in Pharmaceutical Amino Acid Distribution, Supply Security, synthetic manufacturing, technical support, Thomas Hermann, Turkey, United Kingdom
(IN BRIEF) Evonik and Higuchi Inc. have launched a new joint laboratory in Yokohama, Japan, to advance oral drug delivery innovation and support pharmaceutical companies with localized technical expertise. The Open Pharma Lab will provide access to Evonik’s EUDRAGIT® polymers … Read the full press release
Posted in Business, Chemicals, Germany, Industrial, Investment, Management, Pharma & Biotech
Tagged Asia market, biotechnology, drug delivery, EUDRAGIT® Polymers, Evonik expands Asia innovation network with new Yokohama lab in partnership with Higuchi, Evonik Industries, excipients, formulation development, Guido Skudlarek, Healthcare, Higuchi Inc, Open Pharma Lab, pharmaceutical innovation, Wataru Ohama, Yokohama Japan
(IN BRIEF) A collaborative study by the University of Copenhagen and Stanford University has revealed that pharmaceuticals possess unique isotopic signatures—based on stable isotopes of carbon, hydrogen and oxygen—that correspond to their manufacturing conditions. By profiling these δ²H, δ¹³C and … Read the full press release
Posted in Business, Denmark, Education, Financial, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged cellulose, corn starch, counterfeit detection, Else Holmfred, excipients, ibuprofen, isotope-ratio mass spectrometry, isotopes, partnership, pharmaceutical counterfeiting, stable isotope analysis, Stanford University, Stefan Stürup, University of Copenhagen, δ²H, δ¹³C, δ¹⁸O
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?